LINDSAY CHAPPELL: Open Payments
NPI 1992112312 · FAIRLAWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,570 in 78 payments from 17 companies in 2025. Trend: 2023 $2,193 · 2024 $3,531 · 2025 $1,570
Food & beverage: $1,477Education: $93
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $257 |
| ABBVIE INC. | 17 | $224 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $146 |
| PFIZER INC. | 7 | $135 |
| Regeneron Healthcare Solutions, Inc. | 4 | $109 |
| Incyte Corporation | 4 | $104 |
| GENZYME CORPORATION | 4 | $88 |
| Organon LLC | 4 | $85 |
| Novartis Pharmaceuticals Corporation | 4 | $78 |
| Gilead Sciences, Inc. | 3 | $77 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, CIBINQO, OPZELURA, ILUMYA, RINVOQ, COSENTYX.
Industry payments across OH — which companies pay providers there.
